Peregrine Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Sell
205,404
-128,713
-39% -$2.95M 0.14% 229
2026
Q1
$7.36M Sell
334,117
-32,244
-9% -$561K 0.27% 111
2025
Q4
$4.32M Sell
366,361
-18,152
-5% -$233K 0.13% 229
2025
Q3
$6.09M Sell
384,513
-1,151
-0.3% -$16.7K 0.18% 166
2025
Q2
$4.42M Buy
385,664
+64,218
+20% +$724K 0.13% 225
2025
Q1
$4.35M Sell
321,446
-17,692
-5% -$294K 0.14% 221
2024
Q4
$5.73M Buy
+339,138
New +$6.6M 0.17% 196

Other funds holding CC

Peregrine Capital Management's CC Position: Q2 2026 in Review

Peregrine Capital Management reduced its Chemours (CC) stake by 39% in Q2 2026, selling an estimated $2.95M and leaving 205,404 shares worth $4.21M. The position accounts for 0.14% of the portfolio, ranked #229.

Peregrine Capital Management first reported a position in CC in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.36M in Q1 2026. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Peregrine Capital Management held 205,404 shares of Chemours worth $4.21M as of Q2 2026.
  • Peregrine Capital Management sold 128,713 Chemours shares in Q2 2026, an estimated $2.95M.
  • Chemours made up 0.14% of Peregrine Capital Management's portfolio in Q2 2026, its #229 holding.
  • Peregrine Capital Management first reported a position in Chemours in Q4 2024 and has held it in 7 quarters since.
  • Peregrine Capital Management's Chemours position peaked at $7.36M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.